Novavax Shares Rise After Licensing Deal With Pfizer

Novavax, Inc. (NASDAQ:NVAX) shares are trading higher Tuesday after the company announced it entered into a license agreement with Pfizer, Inc. (NYSE:PFE) for use of its Matrix-M adjuvant. Licensing Agreement Details Under the non-exclusive agreement, Pfizer will be...